ArticleScience translational medicine2017
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions.
Marc Damelin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
101 papers cite itlatest 60 shown
this paperpooled itcites it